PIQRAY
LIVE

Serial Number

79219218

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Aug 23, 2017

Add to watchlist:

No watchlists yet
View on USPTO

PIQRAY Trademark

Serial Number: 79219218 • Registration: 5415224

PIQRAY is a trademark filed by NOVARTIS AG on August 23, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

August 23, 2017

Registration Date

March 6, 2018

Published for Opposition

December 19, 2017

Goods & Services

[ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; ] pharmaceutical preparations for the prevention and treatment of cancer and tumors [ ; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]

Filing History

PARTIAL INVALIDATION PROCESSED BY THE IB
Dec 25, 2025 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Nov 11, 2025 INPS
INVALIDATION PROCESSED
Nov 10, 2025 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 15, 2025 INPR
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Oct 15, 2024 NA15
REGISTERED - SEC. 15 ACKNOWLEDGED
Oct 15, 2024 15AK
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Oct 15, 2024 NA71
REGISTERED-SEC.71 ACCEPTED
Oct 15, 2024 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 7, 2024 APRE
INTERNATIONAL REGISTRATION RENEWED
Aug 9, 2024 RNWL
TEAS SECTION 15 RECEIVED
Jun 4, 2024 E15R
TEAS SECTION 71 RECEIVED
Feb 6, 2024 ES71
NOTIFICATION PROCESSED BY IB
May 4, 2018 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Apr 13, 2018 FICS
FINAL DISPOSITION PROCESSED
Apr 13, 2018 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Apr 5, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Mar 6, 2018 R.PR
PUBLISHED FOR OPPOSITION
Dec 19, 2017 PUBO
NOTICE OF PUBLICATION
Nov 29, 2017 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 9, 2017 CNSA
ASSIGNED TO EXAMINER
Nov 2, 2017 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 31, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 23, 2017 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Oct 19, 2017 SDRC